Runto Shares: Benzenesulfonate levamisole ammonium obtained the approval notice for the market application of chemical raw materials.

Announcement from Rundo Group: Rundo Jingmen, a wholly-owned subsidiary, recently received the "Approval Notice for Market Application of Benzenesulfonamide and Atropine Quinidine" issued by the National Medical Products Administration. Benzenesulfonamide and Atropine Quinidine is suitable for adult and children aged 1 month and above for surgical procedures and other therapeutic operations, and can also be used for adult critical care treatment. The approval of this product further enriches the company's product portfolio, enhances the company's market competitiveness, and has a positive impact on the company's future business performance.